Trimedyne, Inc. Premarket Notification
VAPORMAX™ II
22 November 2005
DEC 2 1 2005
VAPORMAX™ II Side Firing Fiber kod: 3 457
This summary of 510(k) safety and effectiveness information is being submitted in
accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
1. Submitter Information: Trimedyne, Inc.
15091 Bake Parkway
Irvine, CA 92618
949-951-3800
Contact Person: Glenn Yeik
President and COO
Summary Date: 22 November 2005
Il. Device Name
Proprietary: VAPORMAX™ II
Common: Laser Fiber
Classification: Accessory to Laser-Powered Instrument
HL Predicate Device
The predicate devices for the VAPORMAX II Side Firing Fiber are:
« VAPORMAX™ Side Firing Fiber cleared under KO50412; and
= UROLASE® Right Angle Laser Fiber cleared under K944204, K954597,
and K970422.
IV. Device Description
The VAPORMAX II is a single use, disposable, side firing, fiber optic energy
delivery device for use with cleared Holmium:YAG lasers.
V. Intended Use
The VAPORMAX II is intended for incision, excision, ablation, vaporization, and
coagulation of soft tissue and may be used with any cleared Holmium laser that
has a compatible connector.
Vi. Technological Characteristics
Like its UROLASE predicate, the VAPORMAX II emits laser energy at an
approximately 90-degree angle by way of direct reflection. The VAPORMAX II
shares most of its design characteristics and all materials with its VAPORMAX
predicate and can therefore be used with up to 100 waits of laser power.
AMAX premarket notification v2 22-Nov-05 1

, * Trimedyne, Inc. Premarket Notification :

VAPORMAX™ {I °

22 November 2005 Ko 5 ? 45 ?

Vil. Nonclinical Data
No nonclinica! data were submitted in this Premarket Notification.

Vill. Clinical Data
No clinical tests were submitted in this Premarket Notification.

IX. Conclusions
The VAPORMAX II performs as intended and has acceptable mechanical
properties when used in accordance with its labeling.

AMAX premarket notification v2 22-Nov-05 2

| ~
é ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
ont Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
DEC 2 1 2005
Trimedyne, Inc.
c/o Morten Simon Christensen
Underwriters Laboratories, Inc.
‘ 455 East Trimble Road
San Jose, California 95131-1230
Re: K053457
Trade/Device Name: VAPORMAX™ II
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in
general and plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: December 12, 2005
Received: December 13, 2005
Dear Mr. Christensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
, use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
if your device is classified (see above) into either class II (Special Controls) or class If] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish
further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination docs not mean that
FDA has made a determination that your device complies with other requirements of the Act or any
Federal statutes and regulations administered by other Federal agencies. You must comply with all
the Act’s requirements, including, but not limited to: registration and listing (21 CPR Part 807).
labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality
systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation
control provisions (Sections 531 -542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device to
proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may abtain other
general information on your responsibilities under the Act from the Division of Small Manufacturers,
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or
at its Internet address http:/Awww.fda.gow/edrh/industry/support/ index.html
Sincerely yours,
CPhabagn Preh ed

oo

Mark N. Melkerson

Acting Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

Indications for Use
510(k) Number (if known): <0) 2 “4s )
Device Name: VAPORMAX™ II
Indications for Use:
The VAPORMAX II is intended for surgical use including: incision, excision, vaporization,
ablation, and coagulation of soft tissue.
The VAPORMAX Hl is indicated for use with any cleared Holmium:YAG 2.1 micrometer
laser with a compatible connector for that laser's cleared indications for use.
Prescription Use X Over-The-Counter Use
, (Part 21 CFR 801 Subpart D) AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
oftware Conch lls 6. ban
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices Page 1 of 1
510(k) Number KOS S48 t _

